Delivery Order SPE2DB20D1109-SPE2DB25FP44K
- Not listed
- The Defense Logistics Agency awarded a $1,786.65 delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $1,723.61 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL. This firm fixed-price, non-set-aside contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $2,122.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL, with an ultimate completion date of July 21, 2025. This non-set-aside contract represents a pediatric or clinical pharmaceutical supply requirement typical of federal medical procurement operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,569.66 for Testosterone Cypionate 200 mg/mL on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of pharmaceutical supply services to support federal medical procurement needs. The contract was not issued under any set-aside program and will be performed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,761.52 on July 22, 2025, for the supply of Testosterone Cypionate 2,000 mg/10mL vials. This firm fixed-price delivery order, which is not set-aside designated, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The award represents a single-item pharmaceutical procurement supporting military healthcare supply...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,191.52 firm-fixed-price contract is for the delivery of Testosterone Cypionate 200 mg/mL medication. The contract has an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- The Defense Logistics Agency awarded a $766.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for testosterone cypionate 200 mg/ml injections. As the prime contractor, Amerisourcebergen will supply the agreed quantities of the injectable pharmaceutical to the DLA from its facility in Conshohocken, Pennsylvania, with performance required from July 26-27, 2023. The delivery order was issued under an existing DLA-wide contract vehicle available for medical commodities....
- The Defense Logistics Agency awarded a $1,149.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561566547 TESTOSTERONE CYP 200 MG/MLML. The prime contractor, Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the products from its location in Conshohocken, Pennsylvania to fulfill the agency's requirements. The period of performance is July 21-24, 2023. As a major provider of medical supplies and...
- The Defense Logistics Agency awarded a $29,200 firm fixed price delivery order to Amerisourcebergen Drug Corporation for TESTOSTERONE CYP 200 MG/MLML under contract number 4561889434. The single day order from August 21-22, 2023 will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania. No additional details were provided about the original solicitation or whether this delivery order is associated with a larger indefinite delivery/indefinite quantity contract vehicle....
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at three hundred forty-seven thousand six hundred sixty-five dollars ($347,665) to Amerisourcebergen Drug Corporation for the delivery of testosterone cypionate 200 mg/ml injections. The single award delivery order was issued against an indefinite-delivery/indefinite-quantity multiple award contract vehicle and has a period of performance from September 20, 2023 to September 21, 2023. Amerisourcebergen will fulfill the...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP44KDelivery Order
The Defense Logistics Agency awarded a $2,117.00 delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on July 23, 2025, with completion expected by July 24, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and veteran healthcare systems through its comprehensive pharmaceutical and medical supply offerings. This delivery order exemplifies the company's role within the DLA's pharmaceutical supply chain, providing hormone treatments and specialized medications to support Defense Health Agency operations and other government healthcare systems. The transaction reflects the ongoing reliance on AmerisourceBergen as a prime pharmaceutical vendor under DLA's centralized medical procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 7/23/25 |